Catalyst
  • Institut Carnot CALYM

    Created in 2011
  • Social networks

    3,125 401 2,341
  • Location

    Lyon, France

    Lyon

    France

  • SIREN

    432730919
  • Other establishments

    LYSARC
  • Engaged entities

    133
    0 0
  • Added in Motherbase

    24 Apr 2025, 4:29 p.m.
Description
  • Value proposition

    Consortium dedicated to partnership-based research on lymphomas

    CALYM is a consortium of organisations dedicated to lymphoma research, acknowledged as “Carnot Institute” since 2011: these are public/parapublic research institutes strongly committed to developing partnership-based research with the socio-economical sphere.

    CALYM was born from the wish shared by several research organisations to create a Consortium for the Acceleration of innovation and its transfer in the field of LYMphoma research. It currently includes 20 organisations with complementary expertise in preclinical, translational and clinical lymphoma research:

    2 non-profit associations:
    – The Lymphoma Study Association (LYSA), a cooperating group that is the international leader of lymphoma research
    – The Lymphoma Academic Research Organisation (LYSARC), plus grande structure académique européenne dédiée aux opérations cliniques dans le domaine du lymphome.

    18 teams dedicated to high-quality public research, located in universities and hospitals all across France, conducting lymphoma research projects

    Lymphoma, Cancer, Partnership research, Preclinical and clinical research, translational research, clinical research, positionning, hematology, immunology, immunotherapy, antibody, blood cancer, proof of concept, clinical assay, lymphoma collection, lymphoma biomarkers, and lymphoma models

  • Original language

    Consortium dédié à la recherche partenariale sur le lymphome


    CALYM est un consortium d’entités de recherche dans le domaine du lymphome labellisé depuis 2011 « Institut Carnot » : institut de recherche public/parapublic ayant des engagements forts en faveur du développement de la recherche partenariale avec le monde socio-économique.

    CALYM est né de la volonté de plusieurs entités de recherche à créer un Consortium pour l’accélération de l’innovation et de son transfert dans le domaine du lymphome. Il regroupe actuellement 20 entités ayant une expertise complémentaire dans la recherche préclinique, translationnelle et clinique dans le domaine du lymphome :

    2 associations de recherche à but non lucratif :
    – The Lymphoma Study Association (LYSA), groupe coopérateur leader international de la recherche sur le lymphome.
    – The Lymphoma Academic Research Organisation (LYSARC), plus grande structure académique européenne dédiée aux opérations cliniques dans le domaine du lymphome.
    18 équipes de recherche publique d’excellence, réparties dans des universités et hôpitaux à travers la France, conduisant des projets de recherche sur le lymphome.

  • Consortium de recherche contre lymphome | Calym

    Consortium de recherche contre lymphome | Calym

  • https://calym.org/en
Entity interactions
Entity TypeTweets Articles
CHU de Clermont-Ferrand CHU de Clermont-Ferrand
Government Administration
Other

12 Feb 2026


CHU de Rennes CHU de Rennes
Hospitals and Health Care
Other

12 Feb 2026


Datacend Datacend
Software Development, healthtech
Other

30 Nov 2025


Agile Capital Markets Agile Capital Markets
Investment Banking
Other

26 May 2025


CARLA Biotherapeutics CARLA Biotherapeutics
Biotechnology Research, biotech, deeptech
Other

23 Nov 2025


Biolevate Biolevate
Software Development, healthtech, deeptech
Other

13 Nov 2025


Mistral AI Mistral AI
it services, Technology, Information and Internet
Other

13 Nov 2025


EXPERTIME EXPERTIME
e-commerce, transporttech, IT Services and IT Consulting, martech, it services, uxtech
Other

13 Nov 2025


IPHC - Institut Pluridisciplinaire Hubert Curien - CNRS IPHC - Institut Pluridisciplinaire Hubert Curien - CNRS
Research Services, deeptech
Other

10 Oct 2025


EFS EFS
Government Administration
Other

6 Oct 2025


Radars
Loading...